News
AAV204 is a novel adeno-associated virus (AAV) capsid from the AIM capsid library licensed by Abeona from the University of ...
Abeona will receive a license payment and potential development, regulatory, and sales milestones, and royalties ...
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Beacon Therapeutics, an ophthalmic gene therapy company and Syncona portfolio company, has exercised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback